Navigation Links
RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
Date:7/14/2010

LAKE FOREST, Ill., July 14 /PRNewswire/ -- RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Bioniche Pharma Holdings Limited ("Bioniche Pharma") to Mylan Inc. ("Mylan"), a leading, global generic and specialty pharmaceutical company, for $550 million in cash.  The closing is conditional on regulatory approval and other customary closing conditions.

Bioniche Pharma is a fully-integrated, global specialty sterile injectable pharmaceutical company based in Ireland with a majority of its sales in the United States.  RoundTable acquired a majority interest in the company in February 2006.  The ICC Private Equity Fund managed by the Venture Capital Division of Bank of Scotland (Ireland) Ltd. is selling its minority shareholding in Bioniche Pharma as part of the transaction.  Bioniche Pharma's revenue increased six-fold during RoundTable's investment period.

"Bioniche Pharma's exceptional management team and dedicated employees have driven the company to become a leading, generic and specialty injectable pharmaceutical company," said Jack McGinley, a Founding Partner of RoundTable and the Chairman of the Board of Bioniche Pharma.  "We believe Mylan is an excellent strategic partner for the company, its employees and customers going forward."

"RoundTable has been an ideal partner for Bioniche Pharma," said Steve Thornton, CEO of Bioniche Pharma.  "They have supported substantial investments in our employees, research and development, facilities and business development activities.  Their operating and transaction teams' relationships, guidance and resources have been instrumental to achieving our success."

"RoundTable has been an excellent, valued-added partner in our Bioniche Pharma investment, and we congratulate the management team and employees in building a strong company," said Pat McGrath, Director, Venture Capital of Bank of Scotland (Ireland) Ltd. and Board Director of Bioniche Pharma.

Deutsche Bank Securities Inc. acted as exclusive financial advisor to Bioniche Pharma.  Kirkland & Ellis LLP acted as lead legal counsel, and Beauchamps Solicitors served as Irish legal counsel to RoundTable.

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry.  RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.  RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model.  RoundTable currently manages $1.1 billion in capital, including two equity funds totaling $900 million and a subordinated debt fund of $200 million.  More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.  


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Justice Department Will Not Oppose CEO Roundtable on Cancers Proposal
3. Roundtable Calls Presidents Embryonic Stem Cell Decision: Bankrupt
4. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
5. RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation
6. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... January 23, 2017 ArisGlobal, a ... sciences, announces agClinical 3.3, the latest version of its ... life science organizations to confidently and efficiently meet new ... manage the electronic trial master file so that compliance ... ...
(Date:1/23/2017)... , Jan. 23, 2017  Therabron Therapeutics, ... a new standard in respiratory care, today announced ... Orphan Medicinal Products has granted Orphan Drug Designation ... of Bronchiolitis Obliterans Syndrome (BOS).  "We ... from the EMA to treat patients diagnosed with ...
(Date:1/23/2017)... , Jan. 23, 2017 MouthWatch LLC announced today ... was ranked as the best intraoral camera on DentalCompare,s list ... #2 spot overall. The #1 product was the CollaPlug ... MouthWatch intraoral camera was "…incredibly popular because it is by ... has a small sticker price, it doesn,t sacrifice quality imaging." ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 23, 2017 , ... OSF Ventures, the corporate ... largest start-up platform headquartered in Silicon Valley that connects startups to corporations and ... signed a three-year agreement to be a corporate sponsor of Plug and Play’s ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... from 140 Buzzies users who entered metrics into the product’s app. The ... The new data showed that within just 30 seconds of using Buzzies, people ...
(Date:1/23/2017)... ... 2017 , ... A Northwestern Pennsylvania addiction treatment center unveiled ... Rehabilitation & Recovery Center’s new website can be found at AlpineSpringsRehab.com . ... and retooled website. The treatment center has also revamped its social media strategy, ...
(Date:1/23/2017)... ... 2017 , ... DMG Productions is proud to announce the ... to broadcast Saturday, January 28, 2017 at 5:00pmEST. , This segment will educate ... the limitations of fatigue monitoring technologies within the mining industry. Today SmartCap is ...
(Date:1/23/2017)... OR (PRWEB) , ... January 23, 2017 , ... Sharon ... to the air to educate listeners about the benefits of making new water infrastructure ... U.S.,” Kleyne said, “it’s appropriate that we expect water infrastructure to become a top ...
Breaking Medicine News(10 mins):